Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10392993 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed LOMA: Long-Term Management of Asthma
Condition: Asthma
Interventions: Procedure: Induced sputum cell counts;   Drug: inhaled corticosteroids and other asthma drugs
2 Completed The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)
Condition: Asthma
Intervention: Drug: SB-240563 (Mepolizumab)

Indicates status has not been verified in more than two years